Head and neck cancer screening in patients eligible for liver transplantation

Castillo-Ledesma, Nathalia; Corriols-Noval, Patricia; López-Simón, Eugenia; Viana-Cora, Aiara; Casafont-Morencos, Fernando; Ezcurra-Acedo, Iranzu; Morales‐Angulo, Carmelo

doi:10.1016/j.otoeng.2020.02.003

Cited by 3 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This demonstrates that pretransplant screening for ENT malignant neoplasms, even in high-risk patients, has a low yield. In liver transplant candidates, it has been suggested to screen all patients with a significant history of smoking [15]. However, the current data set does not provide any evidence to warrant an extrapolation of this recommendation to our population of HTx candidates.…”

Section: Pretransplant Screeningmentioning

confidence: 90%

See 1 more Smart Citation

Evaluation of Routine Ear, Nose, and Throat Screening in Heart Transplant Candidates: A Retrospective Cohort Study

Vroonhof

Roest

Datema

et al. 2023

Transplantation Proceedings

View full text Add to dashboard Cite

Section: Pretransplant Screeningmentioning

confidence: 90%

“…of head and neck cancer are detected, ranging from 0.17% to 1.3% [15,16]. This demonstrates that pretransplant screening for ENT malignant neoplasms, even in high-risk patients, has a low yield.…”

Section: Pretransplant Screeningmentioning

confidence: 99%

Evaluation of Routine Ear, Nose, and Throat Screening in Heart Transplant Candidates: A Retrospective Cohort Study

Vroonhof

Roest

Datema

et al. 2023

Transplantation Proceedings

View full text Add to dashboard Cite

“…The data provided also summarize the guidance previously published 15,33 on suggested time intervals to wait before proceeding with LT and merge with guidance from other transplantation societies. 4,5,[11][12][13][14]21,[34][35][36][37] Each cancer type is stratified with a risk assessment ranging from low to high, and this will be dependent on tumor-node-metastasis stage and receiving standard-of-care treatment. The CSS referenced in the tables is based on literature-reported outcomes in the general population, as data specific to transplant recipients are lacking.…”

Section: Circulating Tumor Dna and Applications In The Lt Settingmentioning

confidence: 99%

Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference

et al. 2021

View full text Add to dashboard Cite

Liver transplant in patients with prior nonhepatic cancer is a matter of concern, needing further research, development, and consensus guidelines. This International Liver Transplantation Society/Sociedad Española De Trasplante Hepático consensus conference document focuses on the role of liver transplantation in patients with a prior history of nonhepatic cancer. This document addresses (1) the evaluation of transplant candidates with prior cancers based on the assessment of prognosis, the natural history of individual cancers, and the emerging role for circulating DNA and minimal residual disease in these patients; (2) the impact of prior treatments, including immunotherapy for prior malignancies; and (3) the surveillance of posttransplant cancer recurrence. The consensus statement is based on previously published guidelines, as well as a review of the current, relevant, published literature.

show abstract